Codexis, Inc. income statement

In fiscal 2025, Codexis, Inc. reported revenue of $70.4m, up 18.6% on the year before, operating income of −$41.7m (a -59.3% margin) and net income of −$44.0m, or −$0.50 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Codexis, Inc.: income statement, annual
Fiscal year	2009Dec 2009	2010Dec 2010	2011Dec 2011	2012Dec 2012	2013Dec 2013	2014Dec 2014	2015Dec 2015	2016Dec 2016	2017Dec 2017	2018Dec 2018	2019Dec 2019	2020Dec 2020	2021Dec 2021	2022Dec 2022	2023Dec 2023	2024Dec 2024	2025Dec 2025	LTMJun 2026
Revenue	83	107	124	88	32	35	42	49	50	61	68	69	105	139	70	59	70	78
Cost of revenue	—	—	—	—	—	—	—	10	14	13	16	14	22	38	13	16	9	10
Gross profit	—	—	—	—	—	—	—	39	36	48	53	55	83	101	57	43	61	68
Research and development	55	52	61	57	32	23	21	22	30	30	34	44	56	80	59	46	52	49
Selling, general and administrative	30	34	37	31	27	22	22	25	29	29	32	35	49	52	53	55	47	43
Operating income	−18	−7	−16	−31	−41	−19	−8	−9	−23	−11	−13	−24	−23	−35	−68	−59	−42	−28
Interest expense	—	1	0	0	0	—	—	—	—	—	—	—	—	—	—	—	—	—
Provision for credit losses	—	—	—	—	—	—	—	—	—	—	0	0	0	0	0	—	—	—
Income before tax	−20	−8	−16	−31	−41	−19	−8	−9	−23	−11	−12	−24	−21	−33	−76	−65	−44	−31
Income tax	0	0	0	0	−0	−0	−0	−0	0	−0	0	0	0	0	0	0	0	0
Net income	−20	−9	−17	−31	−41	−19	−8	−9	−23	−11	−12	−24	−21	−34	−76	−65	−44	−31
Diluted EPS	−$7.74	−$0.35	−$0.46	−$0.84	−$1.08	−$0.50	−$0.19	−$0.21	−$0.50	−$0.21	−$0.21	−$0.40	−$0.33	−$0.51	−$1.12	−$0.89	−$0.50	−$0.34
Diluted shares (average)	—	25m	36m	37m	38m	38m	39m	41m	46m	52m	57m	59m	65m	65m	68m	73m	87m	91m
EBITDA	—	—	—	—	—	—	—	−7	−22	−10	−11	−22	−20	−29	−63	−54	−36	−23

US$ millions unless shown otherwise. Fiscal quarters.

Codexis, Inc.: income statement, quarterly
Quarter	2024 Q3Sept 2024	2024 Q4Dec 2024	2025 Q1Mar 2025	2025 Q2Jun 2025	2025 Q3Sept 2025	2025 Q4Dec 2025	2026 Q1Mar 2026	2026 Q2Jun 2026
Revenue	13	21	8	15	9	39	15	15
Cost of revenue	4	4	3	2	2	2	2	4
Gross profit	9	18	5	13	6	37	13	11
Research and development	12	12	13	14	14	12	11	12
Selling, general and administrative	14	13	12	12	11	11	10	11
Operating income	−17	−7	−20	−13	−19	11	−8	−11
Income before tax	−21	−10	−21	−13	−20	10	−9	−12
Income tax	0	0	0	0	0	0	0	0
Net income	−21	−10	−21	−13	−20	10	−9	−12
Diluted EPS	−$0.29	−$0.11	−$0.25	−$0.16	−$0.22	$0.12	−$0.10	−$0.13
EBITDA	−15	−6	−19	−12	−18	12	−7	−10

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: BNR vs CDXS CDXS vs XGN CDXS vs PSNL CDXS vs HBIO

More: Life Sciences Tools & Services stocks compared, Health Care sector, rankings of US companies

Figures from Codexis, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Codexis, Inc.